CD38, CD38 molecule, 952

N. diseases: 473; N. variants: 7
Disease: ABO incompatibility ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0860218
Disease: ABO incompatibility
ABO incompatibility 		0.010 Biomarker disease BEFREE The use of anti-CD38 therapy with daratumumab to target residual host plasma cells is safe and effective, and it can be considered in refractory recipients with PRCA after allo-HSCT secondary to ABO incompatibility. 31693245 2020